Use of guanethidine for treating hypertension by local vascular delivery

Details for Australian Patent Application No. 2010238744 (hide)

Owner Mercator MedSystems, Inc.

Inventors Seward, Kirk Patrick

Agent FB Rice

Pub. Number AU-A-2010238744

PCT Pub. Number WO2010/124120

Priority 61/186,704 12.06.09 US; 61/171,702 22.04.09 US

Filing date 22 April 2010

Wipo publication date 28 October 2010

International Classifications

A01N 37/52 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing groups, e.g. carboxylic acid amidines

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/124120 Priority application(s): WO2010/124120

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010238745-Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor

2010238743-Azetidinyl diamides as monoacylglycerol lipase inhibitors